AI to match Indian cancer patients with most effective clinical trials

Mumbai: A new artificial intelligence (AI)-based programme will help Indian patients who have a difficult-to-treat cancer find ongoing clinical trials that could best help them.

While “clinical trials” are often viewed with suspicion in India, patient support groups in the western world help gravely ill cancer patients access clinical trials. “Clinical trials are the only way to bring treatment to clinics, but in India we imitate and implement the western findings,” said Dr Kumar Prabhash, professor from Tata Memorial Hospital.